Last update :
28/04/2024
References   References 1949  
Type : Journal

Research teams : Sacramento - University of California Davis medical center, Department of Pharmacy Services
Authors : Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.
Title : Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Reference : Clinical Cancer Research ; 7: 1569-1576. 2001

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionDexrazoxane hydrochloride Cytoprotective
Stability in solutions Not specified Glucose 5% 0,1 & 0,5 mg/ml 25°C Light
24 Hour
Stability in solutions Not specified Glucose 5% 1 mg/ml 25°C Light
12 Hour

  Mentions Légales